Rhianna Shaw | Sep 09, 2011
As “the only congress for drug safety & pharmacovigilance executives and decision makers” the World Drug Safety Congress is a big event for the drug safety industry, bringing together top pharmaceutical, biotechnology and regulatory representatives to address the key issues.
The Congress promises a program that teaches you how to make and fulfil the right safety procedures, strengthen risk management, improve risk communication effectiveness and patient trust, and how to ease regulartory pressure for the full product lifecycle. These talks are all striving to give attendees “great new ideas to do better business.”
The World Drug Safety congress Europe 2011 has announced an eight-part focus:
• Emerging Market Focus
• International Regulatory Roundup
• Risk Management & Communication
• Benefit Risk Decision Making
• Signal Reporting & Management
• Clinical Safety Strategy
• Safety in Early Development
• Observational Studies/Post Approval Safety
Covering an in-depth look at detection, analysis and prevention of adverse drugs using case studies and industry experience from the world over, the programme will offer a lot to companies looking to ensure the successful and safe long-term future of their pharmaceutical drugs.
Filed Under: Pharmaceutical
About the Author: Rhianna Shaw, Conference Hound’s UK correspondent is a 2011 graduate of Brown University with a B.A. in Literary Arts and a course focus on Business. At Brown, Rhianna was the Public Relations and Event Coordinator for the Brown Class Board, responsible for organizing class and campus-wide events. She spent her final semester developing an online start-up with a small team of her Brown classmates. Rhianna hails from sunny England, where she has returned to work in the event industry in London. She has spent a large portion of her life dedicated to music as a member of several bands and orchestras and she also enjoys acting and playing competitive sports!